Appili Therapeutics (APLIF) Q3 2024 Earnings

13AugConfirmed
Nov 22
Feb 23
Q2 2024
Q3 2024
-0.03
-0.02
-0.01
-0.01

Details

Expected EPS
N/A
Actual EPS
-0.007307
Surprise EPS
-0.01
Surprise Percent
+∞%

Description

Appili Therapeutics (APLIF) has reported earnings of -0.007307 per share for Q3 2024.

0 Comments

Share your thoughts